CLL Q&A with Constantine Tam
Professor Tam discusses some common CLL disease characteristics and treatment expectations. He describes some concerns when staring patients on CLL treatment, including the need for good tolerability for long-term treatment. Professor Tam outlines occurrence of relapse and response to subsequent therapy. He offers insight into explaining the risks and benefits of clinical trials to patients and provides and overview of key considerations when treating CLL patients. He introduces the role of BTK inhibition in CLL, challenges in their use, and hopes for the future treatment of CLL.